| Cat. No. |
Product Name |
Information |
| PC-22573 |
VX-150
NaV1.8 inhibitor
|
VX-150 is a highly selective, orally bioavailable NaV1.8 channel inhibitor, shows >400-fold selectivity over other sodium channel subtypes, induces analgesia in a variety of evoked pain tests, without affecting subject safety. |
| PC-22308 |
QLS-81
Nav1.7 inhibitor
|
QLS-81 is a potent, selective Nav1.7 channel inhibitor with IC50 of 3.5 uM for inhibition of Nav1.7 current in whole-cell patch-clamp recording assay. |
| PC-21839 |
S3969
ENaC activator
|
S3969 is a small molecule activator of the human epithelial sodium channel (ENaC) with EC50 of 1.2 uM in ENaC-expressing oocytes. |
| PC-21779 |
XPC-5462
NaV1.2/1.6 inhibitor
|
XPC-5462 is a potent, selective dual inhibitor of NaV1.6 and NaV1.2 with IC50 of 10.9 nM and 10.3 nM, respectively. |
| PC-21778 |
XPC-7224
NaV1.6 inhibitor
|
XPC-7224 is a potent, selective NaV1.6 inhibitor with IC50 of 78 nM and 130 nM for human and mouse NaV1.6, respectively, interacts with the inactivated state of the channel. |
| PC-21711 |
UTX-143
NHE5 inhibitor
|
UTX-143 is a potent, selective sodium-hydrogen exchange subtype 5 (NHE5) inhibitor with IC50 of 3.11 uM, 80-fold selective over NHE1. |
| PC-21230 |
Aneratrigine
Sodium Channel inhibitor
|
Aneratrigine is a sodium channel protein type 9 subunit alpha blocker. |
| PC-20850 |
DS43260857
NaV1.7 inhibitor
|
DS43260857 is a potent, selective NaV1.7 inhibitor with IC50 of 15 nM (hNaV1.7), shows 440-fold and 930-fold selectivity over hNaV1.1 and hNaV1.5, respectively. |
